Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07726342 |
| Consolidated Lead Sponsor | Chengdu SciMount Pharmatech Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 60 participants (ESTIMATED) |
| Registered Start Date | 2026-08-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Beijing Cancer Hospital | Beijing, China | Open Hospital Dossier -> |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, China | Open Hospital Dossier -> |
| Sun Yat-sen University Cancer Center | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.